{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:25:22Z","timestamp":1789435522894,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81422003"],"award-info":[{"award-number":["81422003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570215"],"award-info":[{"award-number":["81570215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Muscle LIM protein (MLP,\n                    <jats:italic>CSRP3<\/jats:italic>\n                    ) is a key regulator of striated muscle function, and its mutations can lead to both hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) in patients. However, due to lack of human models, mechanisms underlining the pathogenesis of MLP defects remain unclear. In this study, we generated a knockout MLP\/CSRP3 human embryonic stem cell (hESC) H9 cell line using CRISPR\/Cas9 mediated gene disruption.\n                    <jats:italic>CSRP3<\/jats:italic>\n                    disruption had no impact on the cardiac differentiation of H9 cells and led to confirmed MLP deficiency in hESC-derived cardiomyocytes (ESC-CMs). MLP-deficient hESC-CMs were found to develop phenotypic features of HCM early after differentiation, such as enlarged cell size, multinucleation, and disorganized sarcomeric ultrastructure. Cellular phenotypes of MLP-deficient hESC-CMs subsequently progressed to mimic heart failure (HF) by 30 days post differentiation, including exhibiting mitochondrial damage, increased ROS generation, and impaired Ca\n                    <jats:sup>2+<\/jats:sup>\n                    handling. Pharmaceutical treatment with beta agonist, such as isoproterenol, was found to accelerate the manifestation of HCM and HF, consistent with transgenic animal models of MLP deficiency. Furthermore, restoration of Ca\n                    <jats:sup>2+<\/jats:sup>\n                    homeostasis by verapamil prevented the development of HCM and HF phenotypes, suggesting that elevated intracellular Ca\n                    <jats:sup>2+<\/jats:sup>\n                    concentration is a central mechanism for pathogenesis of MLP deficiency. In summary, MLP-deficient hESC-CMs recapitulate the pathogenesis of HCM and its progression toward HF, providing an important human model for investigation of CSRP3\/MLP-associated disease pathogenesis. More importantly, correction of the autonomous dysfunction of Ca\n                    <jats:sup>2+<\/jats:sup>\n                    handling was found to be an effective method for treating the in vitro development of cardiomyopathy disease phenotype.\n                  <\/jats:p>","DOI":"10.1038\/s41419-019-1826-4","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:03:30Z","timestamp":1565636610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling"],"prefix":"10.1038","volume":"10","author":[{"given":"Xiaowei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u2019nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-5296","authenticated-orcid":false,"given":"Yongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-4014","authenticated-orcid":false,"given":"Feng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"1826_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0092-8674(00)81878-4","volume":"88","author":"S Arber","year":"1997","unstructured":"Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393\u2013403 (1997).","journal-title":"Cell"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1128\/MCB.00654-09","volume":"29","author":"V Papalouka","year":"2009","unstructured":"Papalouka, V. et al. Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle. Mol. Cell. Biol. 29, 6046\u20136058 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"1826_CR3","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1128\/MCB.00651-14","volume":"34","author":"C Hoffmann","year":"2014","unstructured":"Hoffmann, C. et al. Human muscle LIM protein dimerizes along the actin cytoskeleton and cross-links actin filaments. Mol. Cell. Biol. 34, 3053\u20133065 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"1826_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ymgme.2005.10.008","volume":"88","author":"JM Bos","year":"2006","unstructured":"Bos, J. M. et al. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol. Genet. Metab. 88, 78\u201385 (2006).","journal-title":"Mol. Genet. Metab."},{"key":"1826_CR5","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1161\/01.CIR.0000056522.82563.5F","volume":"107","author":"C Geier","year":"2003","unstructured":"Geier, C. et al. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107, 1390\u20131395 (2003).","journal-title":"Circulation"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1096-7192(03)00142-2","volume":"80","author":"B Mohapatra","year":"2003","unstructured":"Mohapatra, B. et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab. 80, 207\u2013215 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1161\/01.CIR.101.23.2674","volume":"101","author":"O Zolk","year":"2000","unstructured":"Zolk, O., Caroni, P. & Bohm, M. Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation 101, 2674\u20132677 (2000).","journal-title":"Circulation"},{"key":"1826_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCRESAHA.109.206243","volume":"106","author":"R Knoll","year":"2010","unstructured":"Knoll, R. et al. A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ. Res. 106, 695\u2013704 (2010).","journal-title":"Circ. Res."},{"key":"1826_CR9","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1093\/hmg\/ddn160","volume":"17","author":"C Geier","year":"2008","unstructured":"Geier, C. et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum. Mol. Genet. 17, 2753\u20132765 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1826_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","volume":"12","author":"F Lan","year":"2013","unstructured":"Lan, F. et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12, 101\u2013113 (2013).","journal-title":"Cell Stem Cell"},{"key":"1826_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02456-y","volume":"7","author":"Y Xie","year":"2017","unstructured":"Xie, Y. et al. An episomal vector-based CRISPR\/Cas9 system for highly efficient gene knockout in human pluripotent stem cells. Sci. Rep. 7, 2320 (2017).","journal-title":"Sci. Rep."},{"key":"1826_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12642","volume":"7","author":"FP Pankowicz","year":"2016","unstructured":"Pankowicz, F. P. et al. Reprogramming metabolic pathways in vivo with CRISPR\/Cas9 genome editing to treat hereditary tyrosinaemia. Nat. Commun. 7, 12642 (2016).","journal-title":"Nat. Commun."},{"key":"1826_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 11, 855\u2013860 (2014).","journal-title":"Nat. Methods"},{"key":"1826_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0092-8674(94)90192-9","volume":"79","author":"S Arber","year":"1994","unstructured":"Arber, S., Halder, G. & Caroni, P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79, 221\u2013231 (1994).","journal-title":"Cell"},{"key":"1826_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001263","volume":"3","author":"A Tanaka","year":"2014","unstructured":"Tanaka, A. et al. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J. Am. Heart Assoc. 3, e001263 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2013.01.001","volume":"57","author":"T Kraft","year":"2013","unstructured":"Kraft, T. et al. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes. J. Mol. Cell. Cardiol. 57, 13\u201322 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1826_CR17","doi-asserted-by":"publisher","first-page":"130ra147","DOI":"10.1126\/scitranslmed.3003552","volume":"4","author":"N Sun","year":"2012","unstructured":"Sun, N. et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med. 4, 130ra147 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1826_CR18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF02894001","volume":"12","author":"R Schneider","year":"1973","unstructured":"Schneider, R. & Pfitzer, P. [Number of nuclei in isolated human myocardial cells]. Virchows Arch. B Cell Pathol. 12, 238\u2013258 (1973).","journal-title":"Virchows Arch. B Cell Pathol."},{"key":"1826_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.201101100","volume":"194","author":"PA Harvey","year":"2011","unstructured":"Harvey, P. A. & Leinwand, L. A. The cell biology of disease: cellular mechanisms of cardiomyopathy. J. Cell Biol. 194, 355\u2013365 (2011).","journal-title":"J. Cell Biol."},{"key":"1826_CR20","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/hmg\/11.20.2499","volume":"11","author":"M Arad","year":"2002","unstructured":"Arad, M., Seidman, J. G. & Seidman, C. E. Phenotypic diversity in hypertrophic cardiomyopathy. Hum. Mol. Genet. 11, 2499\u20132506 (2002).","journal-title":"Hum. Mol. Genet."},{"issue":"43","key":"1826_CR21","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","volume":"39","author":"Diogo Mosqueira","year":"2018","unstructured":"Mosqueira, D. et al. CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehy249 (2018).","journal-title":"European Heart Journal"},{"key":"1826_CR22","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.bbamcr.2015.10.014","volume":"1863","author":"C Denning","year":"2016","unstructured":"Denning, C. et al. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochim. Biophys. Acta 1863, 1728\u20131748 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"1826_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/CIRCRESAHA.117.310355","volume":"121","author":"M Dewenter","year":"2017","unstructured":"Dewenter, M., von der Lieth, A., Katus, H. A. & Backs, J. Calcium signaling and transcriptional regulation in cardiomyocytes. Circ. Res. 121, 1000\u20131020 (2017).","journal-title":"Circ. Res."},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.stem.2016.01.022","volume":"18","author":"MA Mandegar","year":"2016","unstructured":"Mandegar, M. A. et al. CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs. Cell Stem Cell 18, 541\u2013553 (2016).","journal-title":"Cell Stem Cell"},{"key":"1826_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/01.RES.0000059562.91384.1A","volume":"92","author":"BC Knollmann","year":"2003","unstructured":"Knollmann, B. C. et al. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling. Circ. Res. 92, 428\u2013436 (2003).","journal-title":"Circ. Res."},{"key":"1826_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrcardio.2011.159","volume":"9","author":"N Frey","year":"2011","unstructured":"Frey, N., Luedde, M. & Katus, H. A. Mechanisms of disease: hypertrophic cardiomyopathy. Nat. Rev. Cardiol. 9, 91\u2013100 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"1826_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/6430","volume":"5","author":"HW Lim","year":"1999","unstructured":"Lim, H. W. & Molkentin, J. D. Calcineurin and human heart failure. Nat. Med. 5, 246\u2013247 (1999).","journal-title":"Nat. Med."},{"key":"1826_CR28","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.107.707257","volume":"116","author":"L Chang","year":"2007","unstructured":"Chang, L. et al. Rad GTPase deficiency leads to cardiac hypertrophy. Circulation 116, 2976\u20132983 (2007).","journal-title":"Circulation"},{"key":"1826_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589\u2013600 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1826_CR30","first-page":"1308","volume":"287","author":"BJ Maron","year":"2002","unstructured":"Maron, B. J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287, 1308\u20131320 (2002).","journal-title":"JAMA"},{"key":"1826_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","volume":"19","author":"H Ashrafian","year":"2003","unstructured":"Ashrafian, H., Redwood, C., Blair, E. & Watkins, H. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet. 19, 263\u2013268 (2003).","journal-title":"Trends Genet."},{"key":"1826_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jacc.2012.08.1021","volume":"61","author":"M Bayeva","year":"2013","unstructured":"Bayeva, M., Gheorghiade, M. & Ardehali, H. Mitochondria as a therapeutic target in heart failure. J. Am. Coll. Cardiol. 61, 599\u2013610 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1826_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cardiores.2004.10.025","volume":"65","author":"BJ van den Bosch","year":"2005","unstructured":"van den Bosch, B. J. et al. Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice. Cardiovasc. Res. 65, 411\u2013418 (2005).","journal-title":"Cardiovasc. Res."},{"key":"1826_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.pathol.1.110304.100218","volume":"1","author":"Z Dong","year":"2006","unstructured":"Dong, Z., Saikumar, P., Weinberg, J. M. & Venkatachalam, M. A. Calcium in cell injury and death. Annu. Rev. Pathol. 1, 405\u2013434 (2006).","journal-title":"Annu. Rev. Pathol."},{"key":"1826_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep22788","volume":"6","author":"AM Burkart","year":"2016","unstructured":"Burkart, A. M. et al. Insulin resistance in human iPS cells reduces mitochondrial size and function. Sci. Rep. 6, 22788 (2016).","journal-title":"Sci. Rep."},{"key":"1826_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1152\/physrev.00012.2002","volume":"82","author":"D Fatkin","year":"2002","unstructured":"Fatkin, D. & Graham, R. M. Molecular mechanisms of inherited cardiomyopathies. Physiol. Rev. 82, 945\u2013980 (2002).","journal-title":"Physiol. Rev."},{"key":"1826_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jacc.2014.04.057","volume":"64","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. J. Am. Coll. Cardiol. 64, 451\u2013459 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1826_CR38","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/nm1132","volume":"10","author":"N Frey","year":"2004","unstructured":"Frey, N. et al. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 10, 1336\u20131343 (2004).","journal-title":"Nat. Med."},{"key":"1826_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.yjmcc.2013.07.016","volume":"63","author":"G Fajardo","year":"2013","unstructured":"Fajardo, G. et al. Deletion of the beta2-adrenergic receptor prevents the development of cardiomyopathy in mice. J. Mol. Cell. Cardiol. 63, 155\u2013164 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1826_CR40","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1073\/pnas.95.12.7000","volume":"95","author":"HA Rockman","year":"1998","unstructured":"Rockman, H. A. et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc. Natl Acad. Sci. USA 95, 7000\u20137005 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1826_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10741-009-9146-x","volume":"14","author":"SE Lehnart","year":"2009","unstructured":"Lehnart, S. E., Maier, L. S. & Hasenfuss, G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail. Rev. 14, 213\u2013224 (2009).","journal-title":"Heart Fail. Rev."},{"key":"1826_CR42","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1016\/j.febslet.2007.07.051","volume":"581","author":"A Finkler","year":"2007","unstructured":"Finkler, A., Ashery-Padan, R. & Fromm, H. CAMTAs: calmodulin-binding transcription activators from plants to human. FEBS Lett. 581, 3893\u20133898 (2007).","journal-title":"FEBS Lett."},{"key":"1826_CR43","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1073\/pnas.0405488102","volume":"102","author":"J Heineke","year":"2005","unstructured":"Heineke, J. et al. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. Proc. Natl Acad. Sci. USA 102, 1655\u20131660 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1826_CR44","doi-asserted-by":"publisher","first-page":"36981","DOI":"10.1074\/jbc.R300023200","volume":"278","author":"RB Vega","year":"2003","unstructured":"Vega, R. B., Bassel-Duby, R. & Olson, E. N. Control of cardiac growth and function by calcineurin signaling. J. Biol. Chem. 278, 36981\u201336984 (2003).","journal-title":"J. Biol. Chem."},{"key":"1826_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.200103020","volume":"155","author":"Y Liu","year":"2001","unstructured":"Liu, Y., Cseresnyes, Z., Randall, W. R. & Schneider, M. F. Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers. J. Cell Biol. 155, 27\u201339 (2001).","journal-title":"J. Cell Biol."},{"key":"1826_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198\u2013205 (2002).","journal-title":"Nature"},{"issue":"12","key":"1826_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/antiox7120195","volume":"7","author":"Bong Jhun","year":"2018","unstructured":"Jhun, B. S., O.-Uchi J., Adaniya, S. M., Cypress, M. W. & Yoon, Y. Adrenergic regulation of Drp1-driven mitochondrial fission in cardiac physio-pathology. Antioxidants (Basel) 7. https:\/\/doi.org\/10.3390\/antiox7120195 (2018).","journal-title":"Antioxidants"},{"key":"1826_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/cvr\/cvv230","volume":"109","author":"KY Goh","year":"2016","unstructured":"Goh, K. Y. et al. Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes. Cardiovasc. Res. 109, 79\u201389 (2016).","journal-title":"Cardiovasc. Res."},{"key":"1826_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.RES.85.4.357","volume":"85","author":"T Ide","year":"1999","unstructured":"Ide, T. et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85, 357\u2013363 (1999).","journal-title":"Circ. Res."},{"key":"1826_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","volume":"121","author":"DA Eisner","year":"2017","unstructured":"Eisner, D. A., Caldwell, J. L., Kistamas, K. & Trafford, A. W. Calcium and excitation-contraction coupling in the heart. Circ. Res. 121, 181\u2013195 (2017).","journal-title":"Circ. Res."},{"key":"1826_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","volume":"12","author":"S Tohyama","year":"2013","unstructured":"Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127\u2013137 (2013).","journal-title":"Cell Stem Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1826-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T12:27:49Z","timestamp":1671193669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1826-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1826-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"22 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"610"}}